ADVERTISEMENT
Diagnostic Chains: The Pandemic's Big Bet Is Proving To Be A Dud
Despite the selloff, diagnostic chain stocks are still relatively pricey compared to pharma and healthcare companies.
10 Feb 2023, 07:50 AM IST
Stocks of diagnostic chains trade close to their 52-week lows as earnings woes continue in the third quarter ended December.Most pathology and radiology service providers have missed estimates so far. And analysts are flagging concerns about the limited growth visibility and high valuations.Most of these stocks are trading at high multiples despite a sharp correction in their stock prices post-Covid, Rahul Jeewani, a pharma analyst a...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Members-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT